MMP-2 and -9; gelatinases, are very closely associated with the metastatic properties of lung cancer [39], which suggests that creating potent MMP-2 and MMP-9 inhibitors should be an important goal in lung cancer therapy [31]. The gene discussed is MMP9; the disease is lung carcinoma.